UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Biologics Resources

Welcome to the Biologics resources page: a curated list of presentation videos and slide decks.

These resources were produced from our Biologics and Biosimilars series of events.

Presentation Videos

Designing protein solubility

Salvador Ventura, Professor of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona

Manufacturing/development of innovative biologics – obstacles and opportunities

Ralf Schumacher, Global Head of Bioprocess and Pharmaceutical Development, Boehringer Ingelheim

Designing affinity ligands for downstream process intensification

Hans Henning Von Horsten, Professor, Industrial Biomanufacturing, HTW- Berlin University of Applied Sciences

Presentation Slides

Time-resolved interaction analysis on living cells

Karl Andersson, CEO, Ridgeview

Improved dose decision with comprehensive diagnostics data

Dr Janko Brand, Senior Scientist, Biotez

Designing affinity ligands for downstream process intensification

Dr Hans Henning von Horsten, Professor, Berlin University

Application of solution NMR spectroscopy for characterizing mAb formulations

Alexander Golovanov, Senior Lecturer, Manchester Institute of Biotechnolog

The Trianni Mouse: Best-In-Class Technology for Human Antibody Discovery

David Meininger, Chief Business Officer, Trianni

Strategies for Coping with the Evolving Landscape of Biosimilars Patent Resolution in the United States

Andrew W. Williams, Partner, McDonnell Boehnen Hulbert & Berghoff

Project Management for Biosimilars – from inception through to approval

Anjan Selz, Vice President, Lupin

The journey to “the” antibody: accessing a versatile toolbox

Daniela Teixeira, COO, Fair Journey Biologics

Global Legal Issues Associated with Biosimilars

Lisa V. Mueller, Director Biologics & Vaccines Development, Casimir Jones

Poster Presentations

Rapid development of anti-idiotypic binders using a novel affinity scaffold

Alex Wignall, Alex Davidson, Helen Curd, Rob Ford, James Nuttall, Amanda Nicholl, Matt Johnson Avacta Life Sciences, Wetherby, UK

Ready-to-Use Potency Assays for Bevacizumab, Aflibercept, and Ranibizumab

Alpana Prasad, Paula Urqhart, Hanako Daino-Laizure, Gayatri Paranjpe, Jane Lamerdin, Eurofins DiscoverX, UK

Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors

Jane E. Lamerdin, Hanako Daino-Laizure, Mimi Nguyen, Vikcy Liu, Alpana Prasad and Jennifer Lin-Jones, Eurofins Discover X, UK

Increased lifetime of RPC resins in insulin production by clean-up using WorkBeads 40S

Kajsa Eriksson, Anna Heijbel and Lars Haneskog, Bio-Works,Sweden